HK1128703A1 - Neuroprotective compounds and uses thereof - Google Patents

Neuroprotective compounds and uses thereof

Info

Publication number
HK1128703A1
HK1128703A1 HK09108378.6A HK09108378A HK1128703A1 HK 1128703 A1 HK1128703 A1 HK 1128703A1 HK 09108378 A HK09108378 A HK 09108378A HK 1128703 A1 HK1128703 A1 HK 1128703A1
Authority
HK
Hong Kong
Prior art keywords
neuroprotective compounds
neuroprotective
compounds
dlhw
integer
Prior art date
Application number
HK09108378.6A
Other languages
English (en)
Inventor
Monika Hitzl
Herbert Moessler
Heinz Schnait
Original Assignee
Ever Neuro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ever Neuro Pharma Gmbh filed Critical Ever Neuro Pharma Gmbh
Publication of HK1128703A1 publication Critical patent/HK1128703A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK09108378.6A 2006-05-03 2009-09-11 Neuroprotective compounds and uses thereof HK1128703A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06450065A EP1857463A1 (fr) 2006-05-03 2006-05-03 Peptide à effets neuroprotecteurs
PCT/EP2007/003906 WO2007128493A1 (fr) 2006-05-03 2007-05-03 Composes neuroprotecteurs et leurs utilisations

Publications (1)

Publication Number Publication Date
HK1128703A1 true HK1128703A1 (en) 2009-11-06

Family

ID=37084626

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108378.6A HK1128703A1 (en) 2006-05-03 2009-09-11 Neuroprotective compounds and uses thereof

Country Status (9)

Country Link
US (1) US8034778B2 (fr)
EP (2) EP1857463A1 (fr)
CN (1) CN101426807B (fr)
AT (1) ATE444968T1 (fr)
DE (1) DE602007002716D1 (fr)
EA (1) EA016040B1 (fr)
HK (1) HK1128703A1 (fr)
UA (1) UA94604C2 (fr)
WO (1) WO2007128493A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101831616B1 (ko) 2010-06-15 2018-04-04 그뤼넨탈 게엠베하 통증 치료용 약제학적 병용물
GB2539161A (en) * 2014-11-26 2016-12-14 Neuro-Bio Ltd Neurodegenerative disorders
CN107428800B (zh) 2015-07-08 2020-11-27 中国食品发酵工业研究院 一种抑制ampa受体的活性肽及其制备方法和应用
EP4114843B1 (fr) 2020-07-13 2023-08-16 EVER Neuro Pharma GmbH Procédé de production d'un hydrolysat de protéines de cerveau de mammifère

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69126563T2 (de) 1990-04-12 1998-02-05 Ebewe Arzneimittel Verwendung einer Mischung von Peptiden and Aminosäuren für die Prophylaxis oder Behandlung von Dementia
AUPN568095A0 (en) * 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
RU2155063C1 (ru) * 1999-10-20 2000-08-27 Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" Тетрапептид, стимулирующий функциональную активность нейронов, фармакологическое средство на его основе и способ его применения
MXPA02011727A (es) * 2000-05-26 2003-10-24 Johnson & Johnson Peptidos neuroprotectores.
GB0014870D0 (en) 2000-06-16 2000-08-09 King S College London Peptides
JP2005533855A (ja) * 2002-07-24 2005-11-10 インターツェル・アクチェンゲゼルシャフト 病原性ウイルスからの別のリーディングフレームによりコードされる抗原

Also Published As

Publication number Publication date
EP2032596A1 (fr) 2009-03-11
ATE444968T1 (de) 2009-10-15
DE602007002716D1 (de) 2009-11-19
CN101426807B (zh) 2012-08-29
UA94604C2 (en) 2011-05-25
EP2032596B1 (fr) 2009-10-07
CN101426807A (zh) 2009-05-06
EA016040B1 (ru) 2012-01-30
EP1857463A1 (fr) 2007-11-21
US20090105159A1 (en) 2009-04-23
EA200802273A1 (ru) 2009-04-28
US8034778B2 (en) 2011-10-11
WO2007128493A1 (fr) 2007-11-15

Similar Documents

Publication Publication Date Title
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
IL185275A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
WO2009016462A3 (fr) Bicyclolactames substitués
MX343625B (es) Composiciones plagicidas.
WO2005087724A3 (fr) Nouvelles hydroxy-6-phenylphenanthridines a substitution amido
IL198806A (en) Compounds 4-phenyl-6- (2,2,2-trifluoro-1-phenylethoxy) pyrimidine-2-amino-propanoic acid, preparations containing them and their uses
IL178156A0 (en) Intermediates for the preparation of pramipexole
GB0521508D0 (en) Organic compounds
IN2012DN02609A (fr)
TW200722424A (en) Substituted piperidines
IL175390A0 (en) Parocess for the preparation of telmisartan
TW200626564A (en) Carboxylic acid derivative containing thiazole ring and medical use thereof
WO2006119309A3 (fr) Composes de 19,26,27-trinor-1$g(a), 25-dihydroxyvitamine d3
DE602006019732D1 (de) Indolylmaleimidderivate
WO2007062526A8 (fr) Promedicaments d'inhibiteurs d'aspartyl protease a base de lysine et leurs procedes de fabrication
HK1145172A1 (en) (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
TW200740781A (en) Novel compounds
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MY145788A (en) Antitumoral dihydropyran-2-one compounds
DE502008001158D1 (en) Benzimidazolderivate
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
HK1096548A1 (en) Imidazopyridine-derivatives as inductible no-synthase inhibitors
HK1128703A1 (en) Neuroprotective compounds and uses thereof
EP2151463A3 (fr) Méthylène-di-(cyclohéxylamine) aminopropylé d'alkylat et utilisations associées